Amneal and Macleods Recalled Diabetes and Mental Health Drugs
The FDA issued recall classifications for exenatide and olanzapine products due to manufacturing and quality defects.
Updated on Sept. 30, 2026 in Diabetes
Live Poll
Do you trust that pharmaceutical manufacturers are maintaining high enough standards for your medications?
Amneal Pharmaceuticals and Macleods Pharma have initiated voluntary recalls for thousands of units of medication across the United States. The FDA classified the two actions as Class II and Class III recalls due to delivery system defects and impurities.
Why it matters
Drug recalls are essential regulatory actions intended to protect patients from receiving medication that may be ineffective or potentially unsafe due to manufacturing errors. By pulling these items from the market, the FDA and pharmaceutical companies attempt to maintain strict safety and quality standards for distributed treatments.
Amneal Pharmaceuticals recalled 5,694 prefilled exenatide pens, while Macleods Pharma recalled 22,032 bottles of olanzapine. These actions correspond to Class II and Class III classifications assigned by the FDA.
The players
Amneal Pharmaceuticals
This company is a global pharmaceutical entity that focuses on the development and manufacturing of generic and specialty medicines.
Macleods Pharma
Headquartered in Mumbai, India, this pharmaceutical company specializes in the production of various medications and therapeutic products.
FDA
The Food and Drug Administration is the federal agency responsible for protecting public health by regulating the safety and efficacy of medical products in the United States.
The details
The exenatide recall by Amneal Pharmaceuticals, manufactured in Ahmedabad, India, stems from a delivery system defect that results in empty pens. Meanwhile, the Macleods Pharma recall of olanzapine was triggered by the failure to meet established impurities and degradation specifications.
Timeline
September 30, 2026: The FDA enforcement report was published regarding the drug recalls.
Health Landscape
The action follows the standard enforcement protocols established under the FDA's Class II and Class III recall classification system. This process ensures that pharmaceutical quality discrepancies are categorized by risk level to inform public safety responses.
Patients currently using exenatide or olanzapine should consult their healthcare provider to verify if their specific supply is part of the recalled batches. Checking medication labels against the FDA recall list can prevent the use of ineffective or potentially contaminated drugs.
The takeaway
Maintaining awareness of FDA recall alerts helps patients ensure they are taking safe, high-quality medications as prescribed. You should always keep the original packaging for your prescriptions to make identifying recalled batches easier should an announcement occur.
Further reading
For more information on monitoring health treatments, visit the Diabetes section.
Source note: This article includes information reported by ETPharma.
Live Poll
Do you trust that pharmaceutical manufacturers are maintaining high enough standards for your medications?
